214 related articles for article (PubMed ID: 25605239)
1. Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.
Bruserud Ø; Reikvam H; Fredly H; Skavland J; Hagen KM; van Hoang TT; Brenner AK; Kadi A; Astori A; Gjertsen BT; Pendino F
Oncotarget; 2015 Feb; 6(5):2794-811. PubMed ID: 25605239
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
Kühnl A; Valk PJ; Sanders MA; Ivey A; Hills RK; Mills KI; Gale RE; Kaiser MF; Dillon R; Joannides M; Gilkes A; Haferlach T; Schnittger S; Duprez E; Linch DC; Delwel R; Löwenberg B; Baldus CD; Solomon E; Burnett AK; Grimwade D
Blood; 2015 May; 125(19):2985-94. PubMed ID: 25805812
[TBL] [Abstract][Full Text] [Related]
3. CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.
Astori A; Fredly H; Aloysius TA; Bullinger L; Mansat-De Mas V; de la Grange P; Delhommeau F; Hagen KM; Récher C; Dusanter-Fourt I; Knappskog S; Lillehaug JR; Pendino F; Bruserud Ø
Oncotarget; 2013 Sep; 4(9):1438-48. PubMed ID: 23988457
[TBL] [Abstract][Full Text] [Related]
4. Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison.
Nepstad I; Hatfield KJ; Aasebø E; Hernandez-Valladares M; Brenner AK; Bartaula-Brevik S; Berven F; Selheim F; Skavland J; Gjertsen BT; Reikvam H; Bruserud Ø
Expert Opin Ther Targets; 2018 Jul; 22(7):639-653. PubMed ID: 29889583
[TBL] [Abstract][Full Text] [Related]
5. Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation.
Licciulli S; Cambiaghi V; Scafetta G; Gruszka AM; Alcalay M
Leukemia; 2010 Feb; 24(2):429-37. PubMed ID: 20010624
[TBL] [Abstract][Full Text] [Related]
6. SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.
Yue C; Xie S; Zhong J; Zhao H; Lin Z; Zhang L; Xu B; Luo Y
Sci Rep; 2021 Aug; 11(1):17012. PubMed ID: 34426610
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of growth factor independence 1 expression in patients with
Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Allahbakhshian A; Farsani MA
J Cancer Res Ther; 2020; 16(1):23-27. PubMed ID: 32362605
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
9. Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication.
Kelm RJ; Lamba GS; Levis JE; Holmes CE
J Cell Biochem; 2018 Feb; 119(2):2073-2083. PubMed ID: 28834593
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell Transcriptomics.
Reikvam H
Cells; 2020 Jul; 9(7):. PubMed ID: 32664684
[TBL] [Abstract][Full Text] [Related]
11. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
[TBL] [Abstract][Full Text] [Related]
12. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.
Zhou J; Bi C; Cheong LL; Mahara S; Liu SC; Tay KG; Koh TL; Yu Q; Chng WJ
Blood; 2011 Sep; 118(10):2830-9. PubMed ID: 21734239
[TBL] [Abstract][Full Text] [Related]
13. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
14. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
15. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
16. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
[TBL] [Abstract][Full Text] [Related]
17. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
18. GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.
Katsumura KR; Ong IM; DeVilbiss AW; Sanalkumar R; Bresnick EH
Cell Rep; 2016 Aug; 16(9):2428-41. PubMed ID: 27545880
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.
Landrette SF; Madera D; He F; Castilla LH
Leukemia; 2011 Apr; 25(4):655-62. PubMed ID: 21263445
[TBL] [Abstract][Full Text] [Related]
20. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.
Schuringa JJ; Wierenga AT; Kruijer W; Vellenga E
Blood; 2000 Jun; 95(12):3765-70. PubMed ID: 10845908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
